IMC Chicago’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.18M Sell
191,591
-328,844
-63% -$17.9M ﹤0.01% 1696
2026
Q1
$32.7M Buy
520,435
+449,345
+632% +$35.9M 0.01% 654
2025
Q4
$6.78M Buy
71,090
+51,263
+259% +$5.03M ﹤0.01% 1511
2025
Q3
$1.94M Buy
+19,827
New +$2.05M ﹤0.01% 2249
2025
Q2
Sell
-21,387
Closed -$2.16M 3309
2025
Q1
$2.16M Sell
21,387
-2,726
-11% -$274K ﹤0.01% 1754
2024
Q4
$2.15M Sell
24,113
-7,664
-24% -$675K ﹤0.01% 1818
2024
Q3
$2.66M Buy
31,777
+9,210
+41% +$726K ﹤0.01% 1492
2024
Q2
$1.74M Buy
+22,567
New +$1.65M ﹤0.01% 1644
2024
Q1
Sell
-25,665
Closed -$1.65M 2348
2023
Q4
$1.48M Buy
+25,665
New +$1.37M ﹤0.01% 1309
2019
Q1
Sell
-5,659
Closed -$200K 656
2018
Q4
$200K Buy
+5,659
New +$205K ﹤0.01% 850

Other funds holding BSX

IMC Chicago's BSX Position: Q2 2026 in Review

IMC Chicago reduced its Boston Scientific (BSX) stake by 63% in Q2 2026, selling an estimated $17.9M and leaving 191,591 shares worth $8.18M. The position accounts for ﹤0.01% of the portfolio, ranked #1696.

IMC Chicago first reported a position in BSX in Q4 2018 and has held it in 10 quarters since. The position peaked at $32.7M in Q1 2026. 770 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • IMC Chicago held 191,591 shares of Boston Scientific worth $8.18M as of Q2 2026.
  • IMC Chicago sold 328,844 Boston Scientific shares in Q2 2026, an estimated $17.9M.
  • Boston Scientific made up ﹤0.01% of IMC Chicago's portfolio in Q2 2026, its #1696 holding.
  • IMC Chicago first reported a position in Boston Scientific in Q4 2018 and has held it in 10 quarters since.
  • IMC Chicago's Boston Scientific position peaked at $32.7M in Q1 2026.
  • 770 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on IMC Chicago's 13F filing for Q2 2026, filed 6 Aug 2026.